SUBSCRIBE
SUBSCRIBE
News   Drug Development

Anavex Life Sciences Corp. Announces Its Preclinical Pipeline Of Novel Oncology Therapies

February 12, 2007 | 
1 min read
KELOWNA, BRITISH COLUMBIA -- (MARKET WIRE) -- February 12, 2007 -- Anavex Life Sciences Corp. (the "Company") (OTCBB: AVXL) announces its strategic vision for growth by discovering and developing cutting-edge drugs against solid tumors.
Preclinical
Anavex Life Sciences Corp.
MORE ON THIS TOPIC
Building a rocket. Halftone hands assemble a rocket shaped puzzle. Concept of a startup, new business. Hasty rocket launch. Innovation, teamwork, development of ideas and technologies
Clinical research
BridgeBio Shares Pop Again as Phase III Thyroid Drug Exceeds Investor Expectations
October 29, 2025
 · 
3 min read
 · 
Annalee Armstrong
The factor that changes everything. A critical break. A sudden change in plans. A threat and a danger. Recover from the blow and get back on course. Severe stress. Withstand the blow.
Immunology and inflammation
Aldeyra Cans RASP Asset, Brings Forward Two Others in Pipeline Shakeup
October 29, 2025
 · 
2 min read
 · 
Tristan Manalac
Podcast
Novartis’ Big Buy, Q3 Earnings, Regeneron’s Dropped Cell Therapy, More
October 29, 2025
 · 
1 min read
 · 
Heather McKenzie
Blue human kidneys with a red surface. Kidney disease, medical diagnosis, technology, artificial intelligence, treatment concept. Low-poly futuristic digital style. Wireframe structure. Vector.
Autoimmune disease
Cabaletta’s CAR T Therapy Spurs Remissions in Small Lupus Trial
October 28, 2025
 · 
2 min read
 · 
Tristan Manalac